| 1. |
S?o Juli?o GP, Habr-Gama A, Vailati BB, et al. New Strategies in rectal cancer. Surg Clin North Am, 2017, 97(3): 587-604.
|
| 2. |
Enríquez-Navascués JM, Borda N, Lizerazu A, et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol, 2011, 17(13): 1674-1684.
|
| 3. |
Lopez-Kostner F, Fazio VW, Vignali A, et al. Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum, 2001, 44(2): 173-178.
|
| 4. |
Warrier SK, Heriot AG, Lynch AC. Surgery for locally recurrent rectal cancer: tips, tricks, and pitfalls. Clin Colon Rectal Surg, 2016, 29(2): 114-122.
|
| 5. |
Pilipshen SJ, Heilweil M, Quan SH, et al. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer, 1984, 53(6): 1354-1362.
|
| 6. |
Swedish Rectal Cancer Trial; Cedermark B, Dahlberg M, et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 1997, 336(14): 980-987.
|
| 7. |
van den Brink M, Stiggelbout AM, van den Hout WB, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol, 2004, 22(19): 3958-3964.
|
| 8. |
Simillis C, Baird DL, Kontovounisios C, et al. A systematic review to assess resection margin status after abdominoperineal excision and pelvic exenteration for rectal cancer. Ann Surg, 2017, 265(2): 291-299.
|
| 9. |
Wibe A, Syse A, Andersen E, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum, 2004, 47(1): 48-58.
|
| 10. |
Frasson M, Garcia-Granero E, Parajó A, et al. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study. Colorectal Dis, 2015, 17(8): 689-697.
|
| 11. |
Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer, 1995, 75(4): 939-952.
|
| 12. |
Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg, 2003, 237(4): 502-508.
|
| 13. |
Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum, 2004, 47(10): 1599-1606.
|
| 14. |
Park JK, Kim YW, Hur H, et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg, 2009, 394(1): 71-77.
|
| 15. |
中華人民共和國衛生和計劃生育委員會醫政醫管局, 中華醫學會腫瘤學會分會. 中國結直腸癌診療規范 (2015 版). 中華普通外科學文獻 (電子版), 2015, 9(6): 506-523.
|
| 16. |
Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum, 2005, 48(5): 929-937.
|
| 17. |
Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg, 2001, 88(7): 988-993.
|
| 18. |
Valentini V, Morganti AG, De Franco A, et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer, 1999, 86(12): 2612-2624.
|
| 19. |
Harris CA, Solomon MJ, Heriot AG, et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg, 2016, 264(2): 323-329.
|
| 20. |
Lee DJ, Sagar PM, Sadadcharam G, et al. Advances in surgical management for locally recurrent rectal cancer: how far have we come? World J Gastroenterol, 2017, 23(23): 4170-4180.
|
| 21. |
Faneyte IF, Dresen RC, Edelbroek MA, et al. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer. Dig Surg, 2008, 25(3): 202-207.
|
| 22. |
Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg, 2013, 100(8): 1009-1014.
|
| 23. |
PelvEx Collaborative. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann Surg, 2017, [Epub ahead of print].
|
| 24. |
Rausa E, Kelly ME, Bonavina L, et al. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer. Colorectal Dis, 2017, 19(5): 430-436.
|
| 25. |
You YN, Skibber JM, Hu CY, et al. Impact of multimodal therapy in locally recurrent rectal cancer. Br J Surg, 2016, 103(6): 753-762.
|
| 26. |
Holman FA, Bosman SJ, Haddock MG, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: results of 565 patients of two major treatment centres. Eur J Surg Oncol, 2017, 43(1): 107-117.
|
| 27. |
Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase Ⅱ study. Int J Radiat Oncol Biol Phys, 2006, 64(4): 1129-1139.
|
| 28. |
Wallace HJ 3rd, Willett CG, Shellito PC, et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J Surg Oncol, 1995, 60(2): 122-127.
|
| 29. |
常文舉, 許劍民. 周圍臟器浸潤性結直腸癌的外科治療及其評價. 中國實用外科雜志, 2013, 33(1): 81-84.
|
| 30. |
Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum, 2013, 56(4): 519-531.
|
| 31. |
Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol, 2010, 17(5): 1343-1356.
|
| 32. |
Bhangu A, Ali SM, Brown G, et al. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg, 2014, 259(2): 315-322.
|
| 33. |
姜勇, 萬遠廉, 劉玉村, 等. 局部復發直腸癌 187 例手術療效及預后因素分析. 中華胃腸外科雜志, 2011, 14(8): 582-585.
|
| 34. |
Milne T, Solomon MJ, Lee P, et al. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg, 2013, 258(6): 1007-1013.
|
| 35. |
Milne T, Solomon MJ, Lee P, et al. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dis Colon Rectum, 2014, 57(10): 1153-1161.
|
| 36. |
Moriya Y, Akasu T, Fujita S, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum, 2004, 47(12): 2047-2053.
|
| 37. |
Guo Y, Chang E, Bozkurt M, et al. Factors affecting hospital length of stay following pelvic exenteration surgery. J Surg Oncol, 2017, [Epub ahead of print].
|
| 38. |
王自強, 張元川, 鄧祥兵, 等. 低位直腸癌行后盆腔臟器切除聯合遠端陰道及會陰體切除術后會陰重建的方式及體會. 中國普外基礎與臨床雜志, 2013, 20(11): 1228-1233.
|
| 39. |
Schiltz B, Buchs NC, Penna M, et al. Biological mesh reconstruction of the pelvic floor following abdominoperineal excision for cancer: A review. World J Clin Oncol, 2017, 8(3): 249-254.
|
| 40. |
Devulapalli C, Jia WAT, DiBiagio JR, et al. Primary versus flap closure of perineal defects following oncologic resection: a systematic review and meta-analysis. Plast Reconstr Surg, 2016, 137(5): 1602-1613.
|
| 41. |
Mirnezami AH, Sagar PM. Surgery for recurrent rectal cancer: technical notes and management of complications. Tech Coloproctol, 2010, 14(3): 209-216.
|
1/5
WeChat